Literature DB >> 10812121

Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients.

M Gürsoy1, R Köksal, D Karavelioğlu, T Colak, G Gür, N Ozdemir, S Boyacioğlu, N Bilgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10812121     DOI： 10.1016/s0041-1345(00)00898-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 2.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

Review 3.  New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.

Authors:  Roy D Bloom; Michael F Crutchlow
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

4.  Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

Authors:  Celal Ayaz; Mustafa Kemal Celen; Ugur Nedim Yuce; Mehmet Faruk Geyik
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 5.  Post-Transplantation Diabetes Mellitus.

Authors:  Syed Haris Ahmed; Kathryn Biddle; Titus Augustine; Shazli Azmi
Journal:  Diabetes Ther       Date:  2020-02-24       Impact factor: 2.945
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.